Mersana Therapeutics Inc
F:0M4
Mersana Therapeutics Inc
F:0M4
Price:
5.3075
EUR
Market Closed
Market Cap:
€649.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mersana Therapeutics Inc
F:0M4
|
US |
|
M
|
McCormick & Company Inc
XMUN:MCX
|
US |
|
P
|
PPL Corp
XBER:PP9
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
Betsson AB
OTC:BTSNY
|
SE |
|
F
|
Firstcash Holdings Inc
F:FF6
|
US |
|
Tencent Music Entertainment Group
F:63T
|
CN |
|
S
|
Software AG
XMUN:SOW
|
DE |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0M4's stock price target?
Not Available
0M4 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Mersana Therapeutics Inc?
Projected CAGR
11%
11%
Over the last 8 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 11%.
